CatherineSearsMD
Pulmonology • Indianapolis, INCritical Care Medicine, Thoracic Oncology
Associate Professor, Medicine, Indiana University School of Medicine
Dr. Sears is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1481 W 10th St
# 111P-IU
Indianapolis, IN 46202Phone+1 317-988-3918Fax+1 317-988-3976
Education & Training
Indiana University School of MedicineFellowship, Pulmonary Disease and Critical Care Medicine, 2008 - 2011
Vanderbilt University Medical CenterResidency, Internal Medicine, 2005 - 2008- Indiana University School of MedicineClass of 2005
Certifications & Licensure
IN State Medical License 2008 - 2025- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Clinical Trials
- Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy Start of enrollment: 2017 Apr 13
- Nodify XL2 Classifier Clinical Utility Study in Low to Moderate Risk Lung Nodules Start of enrollment: 2020 Dec 18
Publications & Presentations
PubMed
- 82 citationsKnowledge Gaps and Research Priorities in Immune Checkpoint Inhibitor–related Pneumonitis An Official American Thoracic Society Research StatementCatherine R. Sears, Tobias Peikert, Jennifer D. Possick, Jarushka Naidoo, Mizuki Nishino
American Journal of Respiratory and Critical Care Medicine. 2019-09-15 - 21 citationsDiscovery and development of novel DNA-PK inhibitors by targeting the unique Ku-DNA interaction.Navnath Gavande, Pamela S. VanderVere-Carozza, Katherine S. Pawelczak, Pamela Mendoza-Munoz, Tyler L. Vernon
Nucleic Acids Research. 2020-11-18 - 255 citationsDNA repair targeted therapy: The past or future of cancer treatment?Navnath Gavande, Pamela S. VanderVere-Carozza, Hilary D. Hinshaw, Shadia I. Jalal, Catherine R. Sears
Pharmacology & Therapeutics. 2016-04-01
Press Mentions
bioAffinity Technologies Announces Dr. Martin Tammemägi to Chair Scientific and Medical Advisory BoardSeptember 29th, 2020- Lung Cancer Screenings to Expand for Indiana Veterans Thanks to $1 Million GrantDecember 21st, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
